Journal
AMERICAN JOURNAL OF CHINESE MEDICINE
Volume 42, Issue 4, Pages 935-947Publisher
WORLD SCIENTIFIC PUBL CO PTE LTD
DOI: 10.1142/S0192415X14500591
Keywords
Britanin; Mast Cells; Pro-Inflammatory Cytokines; Nuclear Factor (NF)-kappa B;; Mitogen-Activated Protein (MAP) Kinases; Passive Cutaneous Anaphylaxis (PCA)
Funding
- Traditional Korean Medicine R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0538]
Ask authors/readers for more resources
Mast cells are central players in immediate-type hypersensitvity and inflammatory responses. In the present study, the effects of britanin on the passive cutaneous anaphylaxis (PCA) reaction in mice and on the phorbol 12-myristate 13-acetate and calcium ionophore A23187 (PMACI)-induced production of pro-inflammatory cytokines in human mast cell line (HMC-1) were evaluated. The oral administration of britanin (10-20 mg/kg) decreased the mast cell-mediated PCA reaction in IgE-sensitized mice. In the activity and mechanism of britanin in vitro assay, britanin suppressed the gene expression and secretion of pro-inflammatory cytokines in a dose-dependent manner in HMC-1. In addition, britanin attenuated PMACI-induced activation of NF-kappa B as indicated by the inhibition of the degradation of I kappa B alpha, nuclear translocation of NF-kappa B, NF-kappa B/DNA binding activity assay, and blocked the phosphorylation of p38 MAP kinase, in a dose-dependent manner. We conclude that britanin may have potential as a treatment for allergic-inflammatory diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available